The Trump administration's broadsides against scientific research have caused unprecedented upheaval at the National Cancer ...

Fully cell-free process aims to democratize personalized cancer therapeutics with shorter turnaround and negligible bioburden ...

MSD has stopped development of anti-TIGIT antibody vibostolimab and anti-LAG-3 antibody favezelimab, blowing a hole in its immuno-oncology pipeline.

Cervical cancer is one of the most common tumour types in women, with 14,500 new cases diagnosed every year in the US and 4,300 deaths.

Information about lung cancer symptoms and treatments. Explore the latest medical research on cancers including experimental treatments.